Smoking

Shisha Vibe Announces New Disposable Vape Recycling Scheme in Store

Retrieved on: 
Friday, March 22, 2024
Partnership, Electronic waste, Herbal cigarette, Recycling, Environment, Hazardous waste, Smoking, Land degradation, Environment Agency

London, England, March 22, 2024 (GLOBE NEWSWIRE) -- Shisha Vibe , a highly rated vape store in London that has been serving vapers across the UK with the leading e-liquids, vape flavours, vape tanks and vape kits for over 10 years, is thrilled to announce its new disposable vape recycling scheme that is now being offered across its retail stores.

Key Points: 
  • London, England, March 22, 2024 (GLOBE NEWSWIRE) -- Shisha Vibe , a highly rated vape store in London that has been serving vapers across the UK with the leading e-liquids, vape flavours, vape tanks and vape kits for over 10 years, is thrilled to announce its new disposable vape recycling scheme that is now being offered across its retail stores.
  • The new disposable vape recycling scheme by Shisha Vibe is in partnership with Waste Care, a renowned recycling and waste management service with expertise in hazardous waste removal.
  • “Shisha Vibe is at the forefront of promoting environmental sustainability in the vaping industry, thanks to our groundbreaking partnership with Waste Care,” said a spokesperson for Shisha Vibe.
  • “This collaboration has led to the introduction of a unique disposable vape recycling scheme within our retail stores.

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

Retrieved on: 
Wednesday, March 20, 2024
Research, Harvard Medical School, Massachusetts General Hospital, Nicotine, Smoker, NIH, Society, Smoking, Safety, Bangladesh Technical Education Board, Annual general meeting, Tobacco

March 21, 2024, 11:30 AM GMT: Achieve’s Director of Clinical Operations, Roxann Becco, will present patient-reported outcomes from the Phase 3 ORCA-2 and ORCA-3 clinical trials.

Key Points: 
  • March 21, 2024, 11:30 AM GMT: Achieve’s Director of Clinical Operations, Roxann Becco, will present patient-reported outcomes from the Phase 3 ORCA-2 and ORCA-3 clinical trials.
  • Data collected include trial participants’ experiences, such as cravings and withdrawal symptoms, personal impact on overall health, and opinions on future use.
  • ORCA-V1 evaluated the effectiveness and safety of cytisinicline in users of nicotine e-cigarettes who wanted to quit vaping.
  • The content is the sole responsibility of the authors and does not necessarily represent the official views of the NIH.

Benevis Report Emphasizes the Need to Prioritize Adolescent Dental Health in Honor of World Oral Health Day

Retrieved on: 
Thursday, March 14, 2024
Research, Health, Dental care, Dentistry, Herbal cigarette, Growth, Caregiver, White, Risk, Education, Patient, Adolescence, History, Tooth decay, Children's Health Insurance Program, World Oral Health Day, Impact, Plaque, SDOH, Smoking, Crowding, Ortho, Jaw, Parent, Brace

"Access to quality dental care should be easy, especially when it's essential; however, millions of adolescents face barriers to treatment or lack of dental hygiene resources and education for healthy smiles," said Bryan Carey, CEO of Benevis. "As adolescents move closer to adulthood or further away from the support of their parents' dental insurance coverage, establishing strong oral health habits that they can maintain over a lifetime becomes even more important. This work begins in the household and within their dental home--the ongoing relationship with a dental provider--to prevent the early onset of dental disease and teach healthy behaviors." 

Key Points: 
  • Many oral diseases and harmful health behaviors managed by adults begin in adolescence.
  • Harmful behaviors with implications for adverse oral health outcomes, like dietary habits, smoking, vaping, and substance use, also become more common in adolescent years.
  • In the U.S., social determinants of health (SDOH) have risk factors that are directly linked to poor oral health outcomes and are attributed to social, economic, and geographic barriers.
  • Expanding access to equitable oral healthcare to support dental disparities during this vital stage of life is essential to adolescent health and well-being.

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

Retrieved on: 
Thursday, March 14, 2024
Webcast, International, Smoking, Nicotine

SEATTLE and VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its fourth quarter and year-end 2023 financial results and provide an update on the cytisinicline development program on Thursday, March 28, 2024, at 4:30 PM EST.

Key Points: 
  • SEATTLE and VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its fourth quarter and year-end 2023 financial results and provide an update on the cytisinicline development program on Thursday, March 28, 2024, at 4:30 PM EST.
  • To access the webcast, please use the following link 4Q23 Webcast .
  • Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. & Canada) or 201-689-7817 (International) and referencing conference ID 13744140.
  • A webcast replay will be available approximately three hours after the call and will be archived on the website for 90 days.

El Septimo - The World’s Best Cigar Company - Introduces Vartan The Dragon

Retrieved on: 
Wednesday, March 13, 2024
Environment, Partnership, History, Smoking, Courage, Emperor, Tobacco

Los Angeles, CA, March 13, 2024 (GLOBE NEWSWIRE) -- The renowned cigar manufacturer, El Septimo, in collaboration with the illustrious cigar retailer Vartan Seferian, proudly announces the launch of "Vartan the Dragon," a limited-edition cigar series.

Key Points: 
  • Los Angeles, CA, March 13, 2024 (GLOBE NEWSWIRE) -- The renowned cigar manufacturer, El Septimo, in collaboration with the illustrious cigar retailer Vartan Seferian, proudly announces the launch of "Vartan the Dragon," a limited-edition cigar series.
  • 'Vartan the Dragon' represents the pinnacle of cigar craftsmanship and the essence of what we strive to offer at Ambassador Fine Cigars.
  • “Vartan Seferian, the visionary behind Ambassador Fine Cigars and the inspiration for "Vartan the Dragon," has dedicated his life to elevating the cigar experience.
  • With only 999 boxes available, "Vartan the Dragon" invites connoisseurs to seize this exclusive opportunity to own a piece of cigar history.

Worldwide Anti-Smoking Policies Charted in Comprehensive Index

Retrieved on: 
Wednesday, April 3, 2024
Other Policy Issues, Women, Men, Other Retail, General Health, Tobacco, Public Safety, Public Policy, Government, Other Health, Consumer, Advocacy Group Opinion, Retail, Oncology, Other Communications, Communications, Convenience Store, Philanthropy, Health, White House, Federal Government, Foundation, Herbal cigarette, Innovation, Global health, History, Smoking, European, THP, Nicotine, Multimedia

We Are Innovation, a leading global innovation network, released the 2024 Effective Anti-Smoking Policies Global Index ( https://antismoking.global/ ).

Key Points: 
  • We Are Innovation, a leading global innovation network, released the 2024 Effective Anti-Smoking Policies Global Index ( https://antismoking.global/ ).
  • The Index delves into the intricacies of alternative nicotine products, scrutinizing aspects such as regulatory frameworks, prohibitions, taxation, and governmental measures for switching from smoking.
  • View the full release here: https://www.businesswire.com/news/home/20240402477735/en/
    The top 20 countries in the global anti-smoking index, led by the United Kingdom, Sweden, and Slovakia in the podium positions, collectively impact almost 1 billion people worldwide.
  • The index emphasizes the urgent need for global advancements in anti-smoking policies.

Global Transdermal Medical Patch Market Analysis and Forecast to 2029: Growing Number of Smokers, Rising use for Insulin Delivery and Upswing in Hormonal Deficiencies Drives Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, April 1, 2024
Medical Supplies, Retail, Health, Tobacco, General Health, Pharmaceutical, Biotechnology, Hypersensitivity, Plasma, Obesity, Growth, Prevalence, Rheumatoid arthritis, Application, Incidence, Diabetes, Patient, Pharmacy, Conditional sentence, Chronic pain, Stroke, Hospital, Smoker, Cancer, Nature, Migraine, Distribution, Arthritis, Nausea, Diabetic neuropathy, Smoking, Skin, Pain management, Pain, Allergy, Market, Vomiting, Osteoarthritis, Ageing, Pharmaceutical industry

The "Global Transdermal Medical Patch Market: Analysis By Type, By Application, By Distribution Channel, By Region Size & Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Transdermal Medical Patch Market: Analysis By Type, By Application, By Distribution Channel, By Region Size & Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The global transdermal medical patch market was valued at US$7.88 billion in 2023 and is expected to reach US$10.33 billion by 2029.
  • The global transdermal medical patch market is highly competitive in nature, characterized by fierce competition among industry leaders vying to expand their market presence.
  • The key players in the global transdermal medical patch market are:

Philip Morris International Demonstrates Clear Progress Toward Its Purpose as It Releases 2023 Integrated Report

Retrieved on: 
Thursday, March 28, 2024
Sustainability, Environment, Environmental, Social and Governance (ESG), Tobacco, Professional Services, Consumer, Other Consumer, Retail, Smoke, Philip Morris International, Integration, Materiality, History, Sale, Child, Science, Quality of life, GRI, Intellectual property, United Nations Global Compact, Marketing, Dow Jones, Science Based Targets initiative, FLAG, Information, Woman, ISS, Privacy, Food, Prevalence, ESG, PMI, Research, Classification, Heated tobacco product, Investment, Dow Jones Sustainability Indices, Targets, Farmer, COVID-19, Life, ZYN, Biodiversity, Smoking, Water, IQOS, Toxicology, World Bank

Please visit pmi.com/sustainability to learn more, and read the full 2023 Integrated Report , case studies and market stories , and the Sustainability KPI Protocol 2023 .

Key Points: 
  • Please visit pmi.com/sustainability to learn more, and read the full 2023 Integrated Report , case studies and market stories , and the Sustainability KPI Protocol 2023 .
  • 2 For definition of net revenues related to smoke-free products, see Glossary available on pages 208-212 of PMI Integrated Report 2023.
  • 3 For definition of available for sale, see Glossary available on pages 208-212 of PMI Integrated Report 2023.
  • For definition of low- and middle-income markets, see Glossary available on pages 208-212 of PMI Integrated Report 2023.

United States Cancer Contrast Media (Gadolinium, Iodinated) Market Size, Share & Trends Analysis Report 2024-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 15, 2024
Health, Oncology, Diagnosis, Breast cancer, Gadolinium, Medicine, MRI, Growth, Prevalence, Agent handling, Patient, Public, Private sector, GE HealthCare, Google Images, Lung cancer, Investment, Smoking, Contrast (vision), Air pollution, USD, Government, Iodine, Medical imaging

The "U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report by Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT scans), Application (Breast Cancer, Lung Cancer), and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report by Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT scans), Application (Breast Cancer, Lung Cancer), and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. cancer contrast media market is anticipated to reach USD 1.53 billion by 2030 and is anticipated to expand at a CAGR of 11.7% from 2024 to 2030.
  • Thus, these factors collectively propel the growth of U.S. cancer contrast media market.
  • Iodinated contrast media dominated the type segment with a share of 39.5% in 2023 owing to the increasing medical imaging procedures.

Modern Health Announces Support for “Whole Human Health” With the Launch of Physical Well-Being Pathways

Retrieved on: 
Tuesday, March 12, 2024
Science, Other Professional Services, Research, General Health, Health, Mental Health, Professional Services, Other Health, Well, Depression, HR, Obesity, Longevity, Growth, Learning, Diabetes, Conditional sentence, Mental health, Sleep, CBT, Anxiety, Absenteeism, Quality of life, Collection, Risk, Adolescence, American College, Smoking, Cognitive behavioral therapy, DBT, Workforce, Sports medicine, Physical, Nursing

Modern Health , a leading global workplace mental health platform, today announces its latest Pathways Collection focused on Physical Well-Being.

Key Points: 
  • Modern Health , a leading global workplace mental health platform, today announces its latest Pathways Collection focused on Physical Well-Being.
  • In a groundbreaking move for the company, Modern Health is building a future as the only platform to support mental and physical health across all modalities of care.
  • This inaugural launch of its Physical Well-Being Pathways Collection marks the commencement of a detailed product roadmap dedicated to addressing the crucial intersection of physical and mental health.
  • Modern Health’s vision refuses to compartmentalize mental and physical health, instead creating a path toward lasting wellness and longevity.